Erik K. Fromme, MD, MCR, FAAHPM

Erik K. Fromme, MD, MCR, FAAHPM

Palliative Medicine

Contact Information

Office Phone Number

617-632-6464

Appointments

617-632-6464

Biography

Erik K. Fromme, MD, MCR, FAAHPM

As Director of the Serious Illness Care Program at Ariadne Labs, Erik Fromme, MD, MCR, oversees the research, growth, and spread of the Serious Illness Care Program.Prior to joining Dana-Farber's Outpatient Palliative Care Clinic, Dr. Fromme was the Section Chief and Medical Director for Palliative Care at Oregon Health & Science University, founding their outpatient palliative care program and developing a research program in patient reported outcomes, hospice and palliative care heath service research, and Physician Orders and Life Sustaining Treatment (POLST).Dr. Fromme received his BA in Psychology from the University of Virginia and MD from the University of Oklahoma. He completed residency in Internal Medicine at Oregon Health & Science University as well as a Masters in Clinical Research degree and Interprofessional Fellowship in Ethics. He also completed Fellowships in General Internal Medicine at Johns Hopkins Hospital and Palliative Care at Massachusetts General Hospital and was a Schwartz Fellow in Pastoral Care.

Researcher

Physician

Director, Serious Illness Care Program, Ariadne Labs
Physician
Member of the Faculty, Harvard Medical School

Centers/Programs

Clinical Interests

Communication, Implementation science, Quality of life

Board Certification

  • Hospice and Palliative Medicine, 2005
  • Internal Medicine, 1997

Fellowship

  • Johns Hopkins University
  • Massachusetts General Hospital
  • Oregon Health & Science University

Residency

  • Oregon Health & Science University

Medical School

  • University of Oklahoma College of Medicine

Locations

Location Avtar

Dana-Farber Cancer Institute

450 Brookline Ave. Boston, MA 02215
Get Directions

Dana-Farber Cancer Institute

Location Avtar

Dana-Farber Cancer Institute

450 Brookline Ave. Boston, MA 02215
Get Direction
42.3374, -71.1082

Discovery and Insights